Armata Pharmaceuticals, Inc.
ARMP
$9.00
$0.182.04%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -124.30M | -26.68M | -16.30M | -6.53M | 2.60M |
| Total Depreciation and Amortization | 418.00K | 370.00K | 366.00K | 377.00K | 380.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 117.24M | 20.19M | 10.71M | -229.00K | -12.10M |
| Change in Net Operating Assets | -33.00K | 1.81M | -2.00M | -1.20M | 1.19M |
| Cash from Operations | -6.67M | -4.30M | -7.21M | -7.58M | -7.93M |
| Capital Expenditure | -52.00K | -242.00K | -149.00K | -99.00K | 77.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -52.00K | -242.00K | -149.00K | -99.00K | 77.00K |
| Total Debt Issued | 0.00 | 15.00M | 0.00 | 10.00M | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 658.00K | -- | -- | -- | 0.00 |
| Repurchase of Common Stock | 0.00 | -32.00K | 0.00 | -14.00K | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 658.00K | 14.97M | 0.00 | 9.99M | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.07M | 10.43M | -7.36M | 2.31M | -7.85M |